Raphael J. Landovitz

Also affiliated with University of California, Los Angeles

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 44 papers. Top paper: “Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women”.

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

New England Journal of Medicine(2021)10.1056/nejmoa2101016

N/A

8.3DataRank · unranked

869 citations

Deborah Donnell, Meredith E. Clement, Brett Hanscom, Leslie Cottle, Lara E. Coelho +60 more

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00261-8

N/A

2.0DataRank · unranked

68 citations

Brett Hanscom, Meredith E. Clement, Trần Việt Hà, Esper G. Kallás, Manya Magnus +25 more

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

JAMA(2022)10.1001/jama.2022.22246

N/A

0.948DataRank · unranked

555 citations

Roger Bedimo, Jennifer Hoy, Raphael J. Landovitz, Davey M. Smith, Ellen Eaton +13 more

Myocardial Steatosis Among Antiretroviral Therapy–Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa245

N/A

0.788DataRank · unranked

22 citations

Kim‐Lien Nguyen, Vlad G. Zaha, Kara W Chew, R. L. Morrison, Ntobeko A. B. Ntusi +29 more

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

The Lancet HIV(2023)10.1016/s2352-3018(22)00365-4

N/A

0.626DataRank · unranked

64 citations

Loveleen Bansi‐Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, David van de Vijver +32 more

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00200-x

N/A

0.580DataRank · unranked

14 citations

Brett Hanscom, Zhe Wang, Steven A. Safren, Christina Psaros, Deborah Donnell +61 more

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00053-23

N/A

0.510DataRank · unranked

29 citations

Jessica M. Fogel, Zhe Wang, Estelle Piwowar‐Manning, Ryan Kofron, Amber Moser +24 more

Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

Journal of the International AIDS Society(2025)10.1002/jia2.26401

N/A

0.442DataRank · unranked

18 citations

Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya +17 more

Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate

AIDS Research and Human Retroviruses(2022)10.1089/aid.2022.0044

N/A

0.425DataRank · unranked

16 citations

Kristina M. Brooks, Jennifer Brothers, Kathleen Mulligan, Raphael J. Landovitz, Daniel Reirden +7 more

HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

Journal of the International AIDS Society(2024)10.1002/jia2.26252

N/A

0.417DataRank · unranked

9 citations

Georgia R. Goodman, Jasper S. Lee, Whitney S. Rice, Colleen F. Kelley, Temitope Oyedele +18 more

Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis

AIDS(2021)10.1097/qad.0000000000002907

N/A

0.385DataRank · unranked

12 citations

Ian McGowan, Krista Yuhas, Rhonda M. Brand, Mark A. Marzinke, Yukari C. Manabe +15 more

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00247-9

N/A

0.381DataRank · unranked

11 citations

Christopher B. Hurt, Kathryn E. Stephenson, Yunda Huang, Carmen A. Paez, Chenchen Yu +95 more

A population pharmacokinetic model based on HPTN 077 of long‐acting injectable cabotegravir for HIV PrEP

British Journal of Clinical Pharmacology(2022)10.1111/bcp.15477

N/A

0.373DataRank · unranked

11 citations

Kristin L. Bigos, Mark A. Marzinke, Raphael J. Landovitz, Marybeth McCauley, Susan L. Ford +5 more

Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa555

N/A

0.292DataRank · unranked

6 citations

Raphael J. Landovitz, Myron S. Cohen

The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV

BMC Public Health(2024)10.1186/s12889-024-18946-4

N/A

0.220DataRank · unranked

3 citations

Jill Blumenthal, Sonia Jain, Xiaoying Sun, K. Rivet Amico, Raphael J. Landovitz +5 more

Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study

ACS Pharmacology & Translational Science(2021)10.1021/acsptsci.0c00181

N/A

0.165DataRank · unranked

2 citations

Allyson N. Hamlin, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Liu +14 more

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

UNC Libraries(2025)10.17615/8yt1-yt24

N/A

0.104DataRank · unranked

1 citations

Beatriz Grinsztejn, Omar Sued, Adeola Adeyeye, Estelle Piwowar‐Manning, Meredith E. Clement +26 more

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac415

N/A

0DataRank · unranked

36 citations

Jessica M. Fogel, Elias K. Halvas, Estelle Piwowar‐Manning, Mark A. Marzinke, Ryan Kofron +25 more

A community-partnered approach for diversity in COVID-19 vaccine clinical trials

Journal of Clinical and Translational Science(2022)10.1017/cts.2022.471

N/A

0DataRank · unranked

16 citations

Raphael J. Landovitz, Ejiro Ntekume, Courtney Porter, Rachelle Bross, Robin Hilder +10 more

Using time‐weighted average change from baseline of SARS‐CoV‐2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID‐19

Journal of Medical Virology(2022)10.1002/jmv.28054

N/A

0DataRank · unranked

1 citations

Moni B. Neradilek, Ruanne V. Barnabas, Jenell Stewart, Helen C. Stankiewicz Karita, Raphael J. Landovitz +12 more

COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.27582

N/A

0DataRank · unranked

187 citations

Alejandra Casillas, Yelba Castellon‐Lopez, Lisa N. Mansfield, D’Ann Morris, Juan Barron +8 more

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

UNC Libraries(2020)10.17615/14ka-fe90

N/A

0DataRank · unranked

0 citations

Todd T. Brown, Aleshia Thomas, Joseph J. Eron, Athe Tsibris, Andrea Weiss +82 more

LB-17. Efficacy of Hydroxychloroquine (HCQ) for Post-exposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Blinded, Randomized, Controlled Trial

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa515.1914

N/A

0DataRank · unranked

1 citations

Anna Bershteyn, Helen C. Stankiewicz Karita, Christine Johnston, Lorna E. Thorpe, Angelica C Kottkamp +23 more

Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2022.100416

N/A

0DataRank · unranked

21 citations

Marie‐Claude Boily, Brett Hanscom, Mia Moore, Jeffery Todd, Gabriela Paz‐Bailey +7 more

“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women

BMC Women s Health(2021)10.1186/s12905-021-01348-8

N/A

0DataRank · unranked

37 citations

Jamila K. Stockman, Thupten Phuntsog, Sheldon Morris, Christina Psaros, Raphael J. Landovitz +4 more

Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price

Clinical Infectious Diseases(2023)10.1093/cid/ciad566

N/A

0DataRank · unranked

7 citations

G. Ege Eskibozkurt, Sybil Hosek, Clare Flanagan, Raphael J. Landovitz, Elena Y Jin +8 more

Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots

Journal of Pharmaceutical and Biomedical Analysis(2023)10.1016/j.jpba.2023.115307

N/A

0DataRank · unranked

9 citations

Teresa L. Parsons, Ryann Gollings, Marybeth McCauley, Beatriz Grinsztejn, Raphael J. Landovitz +2 more

Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis

New England Journal of Medicine(2024)10.1056/nejmc2402088

N/A

0DataRank · unranked

35 citations

Sinéad Delany‐Moretlwe, Jessica M. Fogel, Mark A. Marzinke, Estelle Piwowar-Manning, Paul A. Richardson +15 more

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies

Clinical Infectious Diseases(2024)10.1093/cid/ciae143

N/A

0DataRank · unranked

19 citations

Tao Li, Juan Yang, Melanie de Boer, Christoph C Carter, Moupali Das +58 more

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

eScholarship (California Digital Library)(2020)10.17615/m2r7-rg29

N/A

0DataRank · unranked

28 citations

Ian Frank, Susan H. Eshleman, Ken Ho, Robert A. Salata, Jorge Santana +24 more

Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis

Microbiology Spectrum(2024)10.1128/spectrum.00307-24

N/A

0DataRank · unranked

9 citations

Estelle Piwowar-Manning, Amber Moser, Tinia Hill, Shahnaz Ahmed, Vanessa Cummings +15 more

HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084

AIDS Research and Human Retroviruses(2024)10.1089/aid.2024.0049

N/A

0DataRank · unranked

5 citations

Deborah Persaud, Estelle Piwowar‐Manning, Paul Richardson, Joseph Szewczyk, Mark A. Marzinke +19 more

Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1061

N/A

0DataRank · unranked

12 citations

Alexander J.B. Bulteel, Sybil Hosek, Julia H. A. Foote, Kenneth A. Freedberg, Raphael J. Landovitz +8 more

Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf561

N/A

0DataRank · unranked

2 citations

Mark A. Marzinke, Xinnong Li, Deborah Donnell, Robert R. Bies, Craig W. Hendrix +16 more

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

UNC Libraries(2025)10.17615/9zee-gb05

N/A

0DataRank · unranked

0 citations

Beatriz Grinsztejn, Mark A. Marzinke, Brett Hanscom, Alex R. Rinehart, Susan H. Eshleman +26 more

Use of DNA profiling to resolve HIV status in a person using injectable cabotegravir for HIV pre-exposure prophylaxis

Journal of Clinical Pathology(2025)10.1136/jcp-2025-210202

N/A

0DataRank · unranked

0 citations

Mahdi Salih, Kathy Haddaway, Mark A. Marzinke, Christi E. Marshall, Zhe Wang +8 more

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf645

N/A

0DataRank · unranked

0 citations

Jessica M. Fogel, Mark A. Marzinke, Elias K. Halvas, Urvi M. Parikh, John W. Mellors +15 more

PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa329

N/A

0DataRank · unranked

6 citations

Matthew R. Beymer, Ryan Kofron, Robert Bolan, Wilbert Jordan, Richard Haubrich +3 more

Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States

Clinical Infectious Diseases(2021)10.1093/cid/ciab328

N/A

0DataRank · unranked

30 citations

Sonia Jain, Feng He, K. Rivet Amico, Ryan Kofron, Eric Ellorin +11 more

Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial

The Lancet HIV(2021)10.1016/s2352-3018(21)00153-3

N/A

0DataRank · unranked

5 citations

Deborah Donnell, Brett Hanscom, Marybeth McCauley, Beatriz Grinsztejn, Raphael J. Landovitz +1 more

Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305

Journal of Antimicrobial Chemotherapy(2021)10.1093/jac/dkab400

N/A

0DataRank · unranked

5 citations

Krista Yuhas, Kenneth H. Mayer, Raphael J. Landovitz, Mark A. Marzinke, Craig W. Hendrix +7 more

'PrEP'ing for a PrEP Demonstration Project: Understanding PrEP Knowledge and Attitudes Among Cisgender Women

(2021)10.21203/rs.3.rs-153946/v1

N/A

0DataRank · unranked

1 citations

Jamila K. Stockman, Thupten Phuntsog, Sheldon Morris, Christina Psaros, Raphael J. Landovitz +4 more

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab152

N/A

0DataRank · unranked

132 citations

Beatriz Grinsztejn, Jessica M. Fogel, Estelle Piwowar‐Manning, Maoji Li, Lei Weng +25 more

Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County

PLoS ONE(2022)10.1371/journal.pone.0262926

N/A

0DataRank · unranked

56 citations

Laura M. Bogart, Erik D. Storholm, David Goodman‐Meza, Elena Rosenberg-Carlson, Rebecca Cohen +4 more